Economic evaluation of prostate cancer screening: a systematic review

被引：8

作者：

Lao, Chunhuan ^{[1
]}

Brown, Charis ^{[1
]}

Rouse, Paul ^{[2
]}

Edlin, Richard ^{[3
]}

Lawrenson, Ross ^{[1
]}

机构：

[1] Univ Auckland, Hamilton, New Zealand

[2] Univ Auckland, Sch Business, Auckland 1, New Zealand

[3] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand

来源：

FUTURE ONCOLOGY | 2015年 / 11卷 / 03期

关键词：

cost; cost-effectiveness threshold; economic evaluation; prostate cancer; quality of life; screening; ASYMPTOMATIC MEN; COST; ANTIGEN; MORTALITY; PROGRAM; OVERDETECTION; POPULATION; STRATEGIES; VALUES;

D O I：

10.2217/fon.14.273

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

This review, based on published papers, aims to describe the costs of prostate cancer screening and to examine whether prostate cancer screening is cost effective. The estimated cost per cancer detected ranged from Euro1299 in The Netherlands to US$44,355 in the USA. The estimated cost per life-year saved ranged from US$3000 to US$729,000, while the cost per quality-adjusted life year (QALY) was AU$291,817 and Can$371,100. The most appropriate data for economic evaluation of prostate cancer screening should be the cost per QALY gained. The estimated costs per QALY gained by prostate cancer screening were significantly higher than the cost-effectiveness threshold, suggesting that even when based on favorable randomized controlled trials in younger age groups, prostate cancer screening is still not cost effective.

引用

页码：467 / 477

页数：11

共 50 条

[1] Economic Evaluation of Gastric Cancer Screening Strategies: A Systematic Review
Aziz Rezapour
Kamran Irandoust
Maryam Eri
Faeze Foruzanfar
Aghdas Souresrafil
Somayeh Afshari
Seidamir Pasha Tabaeian
Journal of Gastrointestinal Cancer, 2025, 56 (1)
[2] ECONOMIC EVALUATION OF SCREENING AND PREVENTION STRATEGIES FOR OVARIAN CANCER: A SYSTEMATIC REVIEW
Sroczynski, G.
Gogollari, A.
Kuehne, F.
Hallsson, L.
Pashayan, N.
Widschwendter, M.
Siebert, U.
VALUE IN HEALTH, 2018, 21 : S256 - S256
[3] Screening for prostate cancer: A Cochrane systematic review
Ilic, Dragan
O'Connor, Denise
Green, Sally
Wilt, Timothy
CANCER CAUSES & CONTROL, 2007, 18 (03) : 279 - 285
[4] Screening for prostate cancer: A Cochrane systematic review
Dragan Ilic
Denise O’Connor
Sally Green
Timothy Wilt
Cancer Causes & Control, 2007, 18 : 279 - 285
[5] Economic evaluation of treatments for patients with localized prostate cancer in Europe: a systematic review
Becerra, Virginia
Avila, Monica
Jimenez, Jorge
Cortes-Sanabria, Laura
Pardo, Yolanda
Garin, Olatz
Pont, Angels
Alonso, Jordi
Cots, Francesc
Ferrer, Montse
BMC HEALTH SERVICES RESEARCH, 2016, 16 : 1 - 13
[6] Ablative therapy for people with localised prostate cancer: a systematic review and economic evaluation
Ramsay, Craig R.
Adewuyi, Temitope E.
Gray, Joanne
Hislop, Jenni
Shirley, Mark D. F.
Jayakody, Shalmini
MacLennan, Graeme
Fraser, Cynthia
MacLennan, Sara
Brazzelli, Miriam
N'Dow, James
Pickard, Robert
Robertson, Clare
Rothnie, Kieran
Rushton, Stephen P.
Vale, Luke
Lam, Thomas B.
HEALTH TECHNOLOGY ASSESSMENT, 2015, 19 (49) : 1 - +
[7] Economic evaluation of treatments for patients with localized prostate cancer in Europe: a systematic review
Virginia Becerra
Mónica Ávila
Jorge Jimenez
Laura Cortes-Sanabria
Yolanda Pardo
Olatz Garin
Angels Pont
Jordi Alonso
Francesc Cots
Montse Ferrer
BMC Health Services Research, 16
[8] ECONOMIC EVALUATION OF FOCAL THERAPY USED IN THE TREATMENT OF PROSTATE CANCER: A SYSTEMATIC REVIEW
Garg, J.
Madan, T.
Taneja, A.
VALUE IN HEALTH, 2023, 26 (12) : S185 - S185
[9] Economic evaluation of prostate cancer screening with prostate-specific antigen
Imamura, Tomoaki
Yasunaga, Hideo
INTERNATIONAL JOURNAL OF UROLOGY, 2008, 15 (04) : 285 - 288
[10] Screening for prostate cancer: an updated Cochrane systematic review
Ilic, Dragan
O'Connor, Denise
Green, Sally
Wilt, Timothy J.
BJU INTERNATIONAL, 2011, 107 (06) : 882 - 891

← 1 2 3 4 5 →